» Articles » PMID: 37569725

Vitamin D Receptor Deficiency Upregulates Pulmonary Artery Kv7 Channel Activity

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Aug 12
PMID 37569725
Authors
Affiliations
Soon will be listed here.
Abstract

Recent evidence suggests that vitamin D is involved in the development of pulmonary arterial hypertension (PAH). The aim of this study was to analyze the electrophysiological and contractile properties of pulmonary arteries (PAs) in vitamin D receptor knockout mice (). PAs were dissected and mounted in a wire myograph. Potassium membrane currents were recorded in freshly isolated PA smooth muscle cells (PASMCs) using the conventional whole-cell configuration of the patch-clamp technique. Potential vitamin D response elements (VDREs) in Kv7 channels coding genes were studied, and their protein expression was analyzed. mice did not show a pulmonary hypertensive phenotype, as neither right ventricular hypertrophy nor endothelial dysfunction was apparent. However, resistance PA from these mice exhibited increased response to retigabine, a Kv7 activator, compared to controls and heterozygous mice. Furthermore, the current sensitive to XE991, a Kv7 inhibitor, was also higher in PASMCs from knockout mice. A possible VDRE was found in the gene coding for KCNE4, the regulatory subunit of Kv7.4. Accordingly, mice showed an increased expression of KCNE4 in the lungs, with no changes in Kv7.1 and Kv7.4. These results indicate that the absence of in mice, as occurred with vitamin D deficient rats, is not sufficient to induce PAH. However, the contribution of Kv7 channel currents to the regulation of PA tone is increased in Vdr mice, resembling animals and humans suffering from PAH.

Citing Articles

Vitamin D receptor and its antiproliferative effect in human pulmonary arterial hypertension.

Callejo M, Morales-Cano D, Olivencia M, Mondejar-Parreno G, Barreira B, Tura-Ceide O Sci Rep. 2024; 14(1):27445.

PMID: 39523384 PMC: 11551162. DOI: 10.1038/s41598-024-78380-9.


An inverse causal relationship between serum 25-hydroxyvitamin D levels and pulmonary hypertension: A two-sample Mendelian randomization study.

Chao C, Wang M, Mei K, Ma C, Qian Y, Zhang X Pulm Circ. 2024; 14(1):e12350.

PMID: 38456156 PMC: 10918714. DOI: 10.1002/pul2.12350.

References
1.
Perez-Vizcaino F, Cogolludo A, Mondejar-Parreno G . Transcriptomic profile of cationic channels in human pulmonary arterial hypertension. Sci Rep. 2021; 11(1):15829. PMC: 8338963. DOI: 10.1038/s41598-021-95196-z. View

2.
Wang T, Tavera-Mendoza L, Laperriere D, Libby E, MacLeod N, Nagai Y . Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005; 19(11):2685-95. DOI: 10.1210/me.2005-0106. View

3.
Mondejar-Parreno G, Perez-Vizcaino F, Cogolludo A . Kv7 Channels in Lung Diseases. Front Physiol. 2020; 11:634. PMC: 7333540. DOI: 10.3389/fphys.2020.00634. View

4.
Simonneau G, Montani D, Celermajer D, Denton C, Gatzoulis M, Krowka M . Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J. 2018; 53(1). PMC: 6351336. DOI: 10.1183/13993003.01913-2018. View

5.
Yuan X, Wang J, Juhaszova M, Gaine S, Rubin L . Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet. 1998; 351(9104):726-7. DOI: 10.1016/S0140-6736(05)78495-6. View